
Sachin Muralidharan
@sachinmuralid15
Doctoral Student at @OtonkoskiL/@_DiegoBalboa_ lab. Interested in early pancreatic development, transcriptional regulation and single cell omics.
ID: 1197913003074695169
https://www2.helsinki.fi/en/researchgroups/pluripotency-and-disease-modeling/lab-members 22-11-2019 16:21:41
786 Tweet
228 Followers
393 Following


In Science Translational Medicine, scientists harness silica nanoparticles to remodel the spleen into a hospitable, immunosuppressive niche for pancreatic islet transplants, and show evidence of safety and efficacy in mice and macaques with type 1 diabetes. 📄: scim.ag/4kdrb7h


🎙can stem cell-derived beta cells cure diabetes? In this episode, Dr. Raphael Scharfmann (Inserm) & Valeria Sordi (San Raffaele) unpack how close we are, the immune hurdles, & why scale matters. 🎧 Listen now 👉 easd.org/media-centre/p… #diabetes #betaCells #T1D #podcast





Gene editing pioneer David R. Liu discusses baby K.J. Muldoon, the first person treated with a customized gene editing therapy, what made K.J.'s treatment possible, and how on-demand treatments for rare genetic diseases could one day become routine. broad.io/DLQA



Excited to share our new research on the metabolic maturation of stem-cell-derived islets upon murine engraftement. Published today in Diabetologia: link.springer.com/article/10.100… OtonkoskiLab Timo Otonkoski Katajisto Lab MetaStem University of Helsinki #SCislet #betacell #diabetes


Congratulations!! Great work by Eliisa Vähäkangas and team! 👏👏




Type 2 diabetes is often considered a protein misfolding disease. But where are these toxic proteins found? 🤔 🚨In new work out today in Nature Metabolism, we show that mitochondrial protein misfolding (yes mitos🤯) leads to beta cell damage in T2D. 🚨 nature.com/articles/s4225… 1/n


🚨Paper alert!!🚨 I am proud to announce that my postdoc work is now published in Cell Metabolism. HNF1A and A1CF coordinate a beta cell transcription-splicing axis that is disrupted in type 2 diabetes cell.com/cell-metabolis…

New application note from R&D Systems showcases efficient, reproducible generation of iPSC-derived pancreatic islets based on our 2021 Nature Protocols paper. High purity (75–80% C-peptide+/NKX6.1+) & robust glucose-stimulated insulin secretion rndsystems.com/resources/lite… #T1D


